M. Lofberg et al., MYOSIN HEAVY-CHAIN FRAGMENTS AND CARDIAC TROPONINS IN THE SERUM IN RHABDOMYOLYSIS - DIAGNOSTIC SPECIFICITY OF NEW BIOCHEMICAL MAKERS, Archives of neurology, 52(12), 1995, pp. 1210-1214
Background: Myosin is the major structural protein in muscle. Antibodi
es to beta-type heavy meromyosin react with cardiac and slow-twitch sk
eletal muscle. Cardiac TnT and TnI were developed as tissue-specific i
ndicators. Objectives: To study myosin heavy-chain fragments as a dela
yed marker of previous rhabdomyolysis. To examine the cardiac specific
ity of cardiac troponin T (TnT) and cardiac troponin I (TnI) in patien
ts with severe skeletal muscle damage. Design and Methods: Serum myosi
n heavy-chain fragments, TnT, and TnI were studied up to 12 days after
diagnosis in relationship to the serum creatine kinase level in 20 pa
tients with rhabdomyolysis. The mean peak serum creatine kinase activi
ty was 91 300 U/L. Myosin heavy-chain fragments were measured by an im
munoradiometric assay, TnT by a one-step immunoenzymometric assay, and
TnI by an immunoenzymometric assay. Results: Values for serum myosin
heavy-chain fragments were greater than the upper limit of normal in a
ll patients. The peak value (70 times the upper normal limit, on avera
ge) was usually achieved 4 to 7 days after the diagnosis of rhabdomyol
ysis, and it was increased up to 12 days. The peak level of TnT was in
creased in 95% of the patients, and it correlated strongly with the pe
ak activity of serum creatine kinase. The highest TnI value was above
the detection limit of myocardial infarction in 30% of the patients. H
alf of these patients were the only patients with ischemic changes obs
erved on an electrocardiogram performed on admission to the hospital.
Conclusions: The measurement of myosin heavy-chain fragments was usefu
l in the diagnosis of previous rhabdomyolysis up to 12 days. The role
of TnT was negligible as an indicator of cardiac muscle damage in pati
ents with severe rhabdomyolysis. Cardiac TnI is a more tissue-specific
marker for myocardial damage even with concurrent rhabdomyolysis.-